SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Democratic gains in the midterms are driving a sharp selloff in DJT, with traders viewing the results as a political setback for Trump that could diminish the stocks political appeal. The conversation is overwhelmingly bearish, though some traders point to the TAE merger as a potential counterweight or see the dip as a buying opportunity.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs stronger-than-expected quarterly results and upbeat outlook, led by data-center demand, sparked attention, but traders debated the sharp giveback of its initial earnings gains. Bulls point to growth and guidance, while skeptics cite valuation and speculation that election-driven data-center restrictions could weigh on AI spending.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

Democratic gains in the midterm elections have fueled concern that SpaceX could face greater scrutiny of its government contracts and data-center expansion, weighing on sentiment. Traders are split between expecting political and regulatory headwinds and viewing the selloff as overdone, with the Qualcomm-Starlink mobile-network deal cited as a bullish counterpoint.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micros quarterly results topped expectations and its full-year outlook rose on strong AI-server demand, but traders are frustrated that the share-price response has been muted. Bulls point to growth and guidance, while skeptics cite thin margins, cash flow, customer concentration and lingering concerns about management credibility; some also worry that election-related data-center restrictions could weigh on AI infrastructure spending.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

A sharp rebound toward record highs has traders calling a post-election squeeze and rotation into Apple from AI and semiconductor stocks, though some attribute the move to broader market buying rather than election results. The rally is contested: bulls see dip-buying and a safe-haven bid, while bears argue Apples rich valuation and earnings-related margin pressure from rising memory costs remain concerns.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Democrats midterm sweep and the prospect of a divided government sparked a broad relief rally, with traders citing reduced political uncertainty even as some questioned the moves durability. The discussion split between bullish calls that the rally could continue and warnings of a short squeeze or bull trap, alongside concerns that tighter AI and data-center regulation could weigh on tech.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,105,365. The last known price of Bitcoin is 76,984.36452344 USD and is up -0.00 over the last 24 hours. It is currently trading on 12773 active market(s) with $23,094,171,945.49 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins rebound amid reported Democratic gains in the midterm elections has sparked debate, with traders variously attributing the move to relief from election uncertainty, a broader risk-on rally, and short covering. Others argue the political shift could weigh on crypto through tighter regulation, leaving sentiment split between bullish calls for a continued recovery and warnings of another selloff.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazons sharp rebound after its post-earnings selloff is drawing attention, with traders also pointing to the post-election rally and short covering as momentum drivers. Bulls celebrate the recovery, while skeptics question whether aggressive AI spending and negative free cash flow can support it.

Dogecoin (DOGE) is a cryptocurrency . Users are able to generate DOGE through the process of mining. Dogecoin has a current supply of 156,601,782,860.16906072. The last known price of Dogecoin is 0.07442689 USD and is up 0.03 over the last 24 hours. It is currently trading on 1543 active market(s) with $375,234,835.75 traded over the last 24 hours. More information can be found at http://dogecoin.com/.

Dogecoin

Dogecoins prolonged pullback and choppy trading are dominating discussion, with traders debating whether the weakness signals further downside or a buying opportunity ahead of a broader crypto rebound. Some connect the market-wide pressure to Binance hack fears, while others dismiss that as a shakeout; no DOGE-specific catalyst is clearly established.

Riot Platforms, Inc. is a bitcoin mining company, which engages in the provision of special cryptocurrency mining computers. It invests in Verady, Coinsquare, and Tess. It operates through the Bitcoin Mining and Engineering segments. The Bitcoin Mining segment focuses on maximizing ability to successfully mine Bitcoin by growing hash rate. The Engineering segment designs and manufactures power distribution equipment and custom engineered electrical products that provides them the ability to vertically integrate many of the critical electrical components and engineering service. The company was founded on July 24, 2000 and is headquartered in Castle Rock, CO.

Riot Platforms Inc

Riots reported 15-year Corsicana data-center lease with a leading Frontier AI lab is driving attention, alongside its earnings and broader shift from Bitcoin mining toward AI infrastructure. Traders are cheering the large contract as validation of that pivot, while others question execution and whether the lease will translate into durable cash flow, noting that gains have been volatile.

statis crypto Watchlist

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$NVAX I’m hopeful for a September approval for Novavax, but I’m also very untrusting of FDA. Suppose they approve both Pfizer and Moderna, but delay us like last time. I’m sure the hit-pieces claiming “Novavax again has production problems” will come within minutes. Is thit going to be another -50% day?
I’m just having a hard time believing the bullshit games could really come to an end.

Paolo

IberianBullish

Mark Mattola

thomas McNamara

Fernando Czerwinski

$NVAX  I posted how much more difficult it is to produce and manufacture a protein vaccine as apposed to mRNA . One runs like Tom Brady the other like Pat Mahomes  night and day I’m a bull but that has me concerned ?

StockTwits for iOS

Novavax Inc

 I’m hopeful for a September approval for Novavax, but I’m also very untrusting of FDA. Suppose they approve both Pfizer and Moderna, but delay us like last time. I’m sure the hit-pieces claiming “Novavax again has production problems” will come within minutes. Is thit going to be another -50% day?
I’m just having a hard time believing the bullshit games could really come to an end.

Brian Anderson

@OneDollarBob I also hope but unfortunately won&#39;t be surprised if history repeats itself again! it may very well be so! we then witness history in that both company leaders did exactly the same mistakes repeatedly!! Promised a lot delivered nothing! let&#39;s pray this doesn&#39;t happen but JJ is a man of his word and delivers.

 I also hope but unfortunately won't be surprised if history repeats itself again! it may very well be so! we then witness history in that both company leaders did exactly the same mistakes repeatedly!! Promised a lot delivered nothing! let's pray this doesn't happen but JJ is a man of his word and delivers.

@JN25 The news out of Canada is concerning. How do they already know that Novavax will be delayed? Why are they still saying that “the Novavax vaccine is for those who are unwilling or unable to get an mRNA vaccine”? I imagine they’ll keep saying that the mRNA vaccines are “preferred” as well. The average person who is willing to get the vaccine is just going to take what the government recommends, even if it’s bullshit. If they say “mRNA vaccines are preferred”, that’s what most people are going to get. Doesn’t really matter that they don’t work and have a laundry list of side effects.
This all feels too familiar. Stan was “in constant communication with FDA” as well JJ. Hope you’re paying attention.

 The news out of Canada is concerning. How do they already know that Novavax will be delayed? Why are they still saying that “the Novavax vaccine is for those who are unwilling or unable to get an mRNA vaccine”? I imagine they’ll keep saying that the mRNA vaccines are “preferred” as well. The average person who is willing to get the vaccine is just going to take what the government recommends, even if it’s bullshit. If they say “mRNA vaccines are preferred”, that’s what most people are going to get. Doesn’t really matter that they don’t work and have a laundry list of side effects.
This all feels too familiar. Stan was “in constant communication with FDA” as well JJ. Hope you’re paying attention.

@OneDollarBob  CDC is agreeing with their studies

StockTwits For Android 

𝕱𝖗𝖆𝖓𝖐𝖎𝖊 𝕾𝖒𝖎𝖑𝖊𝖟

@OneDollarBob  JJ and his team must have done thorough evaluations of why Stan failed and do everything they can to not repeat the same mistakes! Feels risky and feels worrying that history is repeating itself again.

  JJ and his team must have done thorough evaluations of why Stan failed and do everything they can to not repeat the same mistakes! Feels risky and feels worrying that history is repeating itself again.

@OneDollarBob Problem is they’re not effectively communicating with investing communities. They’ve been producing batches of 6K for XBB 1.5 &amp; 1.6 in Q1 based on what Filip said in Q1 ER call. Also BioLogics is fully functional &amp; got its certification in April ( leading to $350 m renegotiation of previous contracts.) As far as USFDA, Estimated/projected US revenue for 2023 is so ridiculously low that I seriously think we’re better off shifting revenue objectives if slow walking golden standard is only applied to Novavax for obvious reasons.

 Problem is they’re not effectively communicating with investing communities. They’ve been producing batches of 6K for XBB 1.5 & 1.6 in Q1 based on what Filip said in Q1 ER call. Also BioLogics is fully functional & got its certification in April ( leading to $350 m renegotiation of previous contracts.) As far as USFDA, Estimated/projected US revenue for 2023 is so ridiculously low that I seriously think we’re better off shifting revenue objectives if slow walking golden standard is only applied to Novavax for obvious reasons.

Sammy Leonidas

@DrSammy I agree with everything you’re saying, but if production is going so smoothly (and I think that it is) what’s the deal with Canada?

 I agree with everything you’re saying, but if production is going so smoothly (and I think that it is) what’s the deal with Canada?

@OneDollarBob imo, this new agreement/arrangement is a positive sign &amp; Canadian government is 100 % behind it. They have made substantial investment in BioLogics &amp; I’m sure they are as excited as we are to move forward w/ fall deployments! But we don’t what’s really going on &amp; their silence leads to speculation

 imo, this new agreement/arrangement is a positive sign & Canadian government is 100 % behind it. They have made substantial investment in BioLogics & I’m sure they are as excited as we are to move forward w/ fall deployments! But we don’t what’s really going on & their silence leads to speculation

@OneDollarBob if Nova enters the market unrestricted, there’s no way, at least cost wise, they can compete with it in private markets.

 if Nova enters the market unrestricted, there’s no way, at least cost wise, they can compete with it in private markets.

@OneDollarBob  What if production problems are true as you know this is a protein vaccine ?

  What if production problems are true as you know this is a protein vaccine ?

@TomMac64 Well, I suppose that is possible? But, since they’re partnered with the world’s largest vaccine producer…and protein vaccines have been produced for decades, I’m hoping that’s not the case.

 Well, I suppose that is possible? But, since they’re partnered with the world’s largest vaccine producer…and protein vaccines have been produced for decades, I’m hoping that’s not the case.

@OneDollarBob  yes they have been produced for decades but never like this they are not designed to be produced in months or have the ability to pivot quickly to something new and don’t forget NVAX cut workforce by at least 30% probably more what will that mean and I also don’t like how they used the term fall I’m starting to think late Oct early Nov ?

  yes they have been produced for decades but never like this they are not designed to be produced in months or have the ability to pivot quickly to something new and don’t forget NVAX cut workforce by at least 30% probably more what will that mean and I also don’t like how they used the term fall I’m starting to think late Oct early Nov ?